Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus
Modified measles virus (MV) has effective oncolytic activity preclinically and is currently being investigated in clinical trials for various types of cancer. We investigated the use of cystine knot proteins (CKPs) to direct MV activity. CKPs are short polypeptides that bind their targets with high...
Main Authors: | Sangeet Lal, Corey Raffel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S237277051730044X |
Similar Items
-
Advances in the design and development of oncolytic measles viruses
by: Hutzen B, et al.
Published: (2015-08-01) -
Retargeting of Viruses to Generate Oncolytic Agents
by: M. H. Verheije, et al.
Published: (2012-01-01) -
Oxidative folding of a cystine knot protein
by: CÌŒemazar, Masa
Published: (2003) -
Measles Virus as an Oncolytic Immunotherapy
by: Christine E. Engeland, et al.
Published: (2021-02-01) -
Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)